ERBB2 and breast cancer: The integration ofmultiple treatment modalities aims to maximize therapeutic efficacy, overcomeresistance, and improve patient outcomes [46].Several approaches have been introduced to optimize combination therapies forpatients with HER2-positive BC [47].